Advertisement Derma Sciences Establishes International Subsidiary In London - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Derma Sciences Establishes International Subsidiary In London

Derma Sciences, a pharmaceutical and medical device company focused on advanced wound care, has established an international subsidiary, Derma Sciences Europe, and will soon be opening an office near London.

Derma Sciences has hired Maeve Kelly as managing director for EMEA (Europe, Middle East, Africa regions). Ms Kelly will report directly to Barry Wolfenson, executive vice president of global marketing and business development.

Prior to joining Derma Sciences, Ms Kelly was international sales manager for Clearstream Technologies. From 2004 to 2008, Ms Kelly held a similar role at Medline Industries. Before working at Medline, Ms Kelly worked in management and sales roles at Microtek Medical, Saf-T-Pak, Kimberly-Clark, and Universal Hospital Supplies.

Edward Quilty, chairman and CEO of Derma Sciences, said: “Our key product, Medihoney is already sold in Europe through distributors in such countries as Germany, Ireland, and Austria. In the UK, we will employ several direct sales representatives.

“We are confident that Medihoney’s brand name recognition will help Derma open doors throughout the continent and provide our sales force with a platform to expose customers to our other advanced wound care products, including the Xtrasorb line and Algicell Ag.

“We believe that these novel products will provide clinicians with more effective and cost-efficient dressings to manage wounds and burns, just as they have in the North American market.”